Interdisciplinary Team

Shari Thomas is the Vice President of Clinical Operations at Strand Therapeutics. With nearly three decades of extensive experience in Oncology Clinical Trial Research, Shari has established herself as a seasoned professional in the field. Her career began as a lab technician in the Army, where she supported the renowned Walter Reed Army Hospital. Over the years, Shari has taken on various pivotal roles, and her expertise is backed by her work with prestigious institutions such as the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Her experience also extends to large pharma, mid-sized companies, as well as small biotech firms. Shari holds a master’s degree in biotechnology from the University of Maryland and dual B.A/B.S. degrees in Sociology and Psychology from Mary Baldwin College.

Subhawana Subba is an Associate Scientist I in the Bioanalytical Sciences group. She holds a Master of Science in Biotechnology from Northeastern University in Boston. Previously, Subhawana worked as a bioanalytical co-op at Strand. She has worked as a graduate student researcher at Dr. Amiji’s lab at Northeastern University on the oral gene delivery project. She has a Bachelor of Engineering in Biotechnology and transitioned from her role as an R&D Associate in sustainable agriculture to pursue her passion for innovative science that improves patient health and quality of life.

Weiyu is a Principal Scientist in the LNP discovery group at Strand Therapeutics. Her research expertise involves the development of functional drug/gene delivery systems. Weiyu received her Ph.D. in Pharmaceutical Sciences from the Ohio State University, where she worked on developing lipid nanoparticles for mRNA based therapeutics. She also holds an M.S. degree in Pharmaceutics and a B.S. degree in Pharmacy from Peking University Health Science Center. Weiyu has authored and co-authored peer-reviewed publications in journals, such as Nature Nanotechnology, Nature Cancer, Nature Biomedical Engineering, Science Advances, and Chemical Science and Biomaterials.

Wuhbet is a Senior Associate Manager, In Vivo Discovery at Strand Therapeutics. She is an experienced researcher with a demonstrated history of contributing to the development of novel vaccine platforms. Her primary focus as a former member of the Irvine Lab in the Koch Institute at MIT was targeted and temporally controlled delivery of cancer immunotherapies and HIV vaccines. Her background includes extensive experience as Environmental Health and Safety personnel to ensure compliance of lab practices, a certificate in Biomedical Laboratory Sciences from Boston University, and B.S. in Biology from University Of Asmara.

Zach Webb is an Associate Scientist of Process Development and he is working cross-functionally to support mRNA production and LNP Formulation scale up efforts. Zach completed his B.S. in Biochemistry at Northeastern University in 2023. During his time at Northeastern he completed two co-ops in process development, one at Wave Life Sciences and the second here at Strand.

Zhijun Su is a Principal Associate Scientist at Strand Therapeutics. She is currently supporting Strand’s cancer immunotherapy program. She is adept at RNA synthesis, immunological analyses, running mouse models, and keeping the lab organized. Prior to Strand, she worked at Koch Institute of Integrative Cancer Research at MIT, Irvine Lab, where she worked on a number of mouse animal studies, and supported cell culture and molecular biology experiments. She earned her B.S. in Biochemistry and Molecular Biology from the University of Massachusetts Amherst.